26 results on '"Cardoso, F."'
Search Results
2. IN33 MANAGEMENT OF A PATIENT WITH ADVANCED BREAST CANCER AND HIV
3. 3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)
4. SA 11.3 Can we omit adjuvant endocrine therapy?
5. P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study
6. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
7. Additional prognostic value of the 70-gene signature (MammaPrint®) among breast cancer patients with 4–9 positive lymph nodes
8. 1st International consensus guidelines for advanced breast cancer (ABC 1)
9. Triple negative breast cancer: Proposals for a pragmatic definition and implications for patient management and trial design
10. Management of breast cancer in men
11. De-escalation of early breast cancer therapy: Umberto Veronesi’s legacy
12. Perspectives on preoperative systemic treatment and breast conservative surgery: One step forward or two steps back?
13. The best use of chemotherapy in the adjuvant setting
14. New data on chemotherapy in the adjuvant setting
15. How the recent data from metastatic trials inform us on treatment opportunities for patients with early breast cancer?
16. Cosmetic result and safety in synchronous bilateral breast cancer (SBBC) patients treated with hypofractionated simultaneous integrated boost intensity modulated radiotherapy (HF-SIB-IMRT)
17. SA 10.2 - Management of breast cancer in men
18. SA 0.1 - De-escalation of early breast cancer therapy: Umberto Veronesi’s legacy
19. Squamous cell carcinoma of the breast
20. Corrigendum to “3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)” [Breast 31 (February 2017) 244–259]
21. Editorial: Why are guidelines not followed in clinical practice?
22. P205 - Cosmetic result and safety in synchronous bilateral breast cancer (SBBC) patients treated with hypofractionated simultaneous integrated boost intensity modulated radiotherapy (HF-SIB-IMRT)
23. SA 5.4 - How the recent data from metastatic trials inform us on treatment opportunities for patients with early breast cancer?
24. 0072 The 70-gene MammaPrint signature for optimal risk stratification in endocrine responsive breast cancer
25. 0073 The 70-gene MammaPrint signature is predictive for chemotherapy benefit in early breast cancer
26. S3 The evolution of treatment strategies: Aiming at the target
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.